Skip to main content
. 2021 Sep 14;12(6):1477–1488. doi: 10.1002/jcsm.12776

Table 2.

Nutritional characteristics (N = 1030)

Features Total (N = 1030) No cachexia a (N = 496) With cachexia a (N = 534)
N % N % N %
BMI (kg/m2)
<20 132 12.8 20 4.0 112 21.0
20–24.9 429 41.7 179 36.1 250 46.9
25–29.9 307 29.8 197 39.7 110 20.6
≥30 161 15.6 100 20.2 61 11.4
Weight loss within previous 6 months
Minimal (≤5%) 549 53.3 496 100.0 53 9.9
Moderate (>5% to <10%) 213 20.7 0 0.0 213 39.9
Severe (≥10%) 268 26.0 0 0.0 268 50.2
Sarcopenia, SARC‐F score ≥ 4 389 37.8 112 22.6 277 51.9
Upper arm circumference (missing data n = 42)
<21 cm 66 6.7 11 2.3 55 10.8
21–22 cm 120 12.1 41 8.5 79 15.6
>22 cm 802 81.2 429 89.2 373 73.6
Poor dental health status (missing data n = 17) 221 21.8 91 18.6 130 24.8
Low food intake (≤2/3 of last meal) (missing data n = 17) 236 23.3 46 9.4 190 36.3
Dysgueusia (missing data n = 16) 127 12.5 44 9.0 83 15.8
Low serum albumin (<35 g/L) (missing n = 325) 280 39.7 85 26.6 195 50.6
High serum CRP (≥10 mg/L) (missing data n = 391) 338 52.9 109 38.9 229 63.8
Nutritional support (missing data n = 20) 393 38.9 98 20.3 295 55.9
Fortified diet 204 51.9 53 54.1 151 51.2
Oral nutritional supplements 323 82.2 77 78.6 246 83.4
Enteral nutrition 18 4.6 0 0.0 18 6.1
Parenteral nutrition 17 4.3 3 3.1 14 4.7

BMI, body mass index; CRP, C‐reactive protein; SARC‐F, Strength, Assistance with walking, Rise from chair, Climb stairs and Falls score.

a

Cachexia was defined as the presence of one or more of the following criteria: weight loss >5% over the previous 6 months; or BMI < 20 kg/m2 and weight loss >2%; or abnormal SARC‐F score (≥4/10) and weight loss >2%.